---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-088576"
form_type: "8-K"
ticker: null
cik: "0001178879"
company_name: "AMICUS THERAPEUTICS, INC."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T00:49:43.900987+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amicus Q2 rev $94.5M (+17% YoY); raises Galafold guidance to 14-18% growth; CFO Quimi to retire

## Summary
- Q2 2023 total revenue $94.5M (+17% YoY at CER); net loss $43.2M ($0.15/sh), improved from $62.2M loss YoY.
- Full-year Galafold revenue growth guidance raised to 14-18% at CER; non-GAAP operating expense guidance cut to $330M-$350M.
- Company on track for non-GAAP profitability in H2 2023; expects U.S. and U.K. approvals of AT-GAA (Pombiliti+Opfolda) in Q3 2023.
- CEO Quimi to retire; CFO role search underway with identified candidates; she will stay until successor appointed.
- European launch of Pombiliti+Opfolda initiated in Germany; reimbursement discussions in additional EU countries ongoing.

## SEC filing metadata
- accession: 0001104659-23-088576
- form_type: 8-K
- cik: 0001178879
- company_name: AMICUS THERAPEUTICS, INC.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178879/000110465923088576/0001104659-23-088576-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178879/000110465923088576/tm2323120d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-088576
- JSON: https://secwatch.observer/filing/0001104659-23-088576.json
- Plain text: https://secwatch.observer/filing/0001104659-23-088576.txt

## Key facts
- Executive change
  Daphne Quimi departed as Chief Financial Officer at AMICUS THERAPEUTICS, INC..
  - Action: intends to retire
  - Role: Chief Financial Officer
  source text: The Company announced today that Daphne Quimi, the Company’s Chief Financial Officer, notified the Company on August 3, 2023 that she intends to retire before the end of 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178879/000110465923088576/0001104659-23-088576-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.